Screening for quality of platelet concentrates by testing for EDTA-induced platelet shape changes
A colleague in the United Kingdom wishes to share data regarding a method of screening for quality of platelet concentrates, based on EDTA-induced platelet shape changes. The UK colleague is of the belief that such an approach might have some utility for interdicting unacceptable platelet products, such as those contaminated by bacterial growth. This PDF document (provided by the UK colleague) contains specifics about EDTA-induced platelet shape change detection. The UK colleague wonders if other laboratories screen for quality of platelet concentrates by testing for EDTA-induced platelet shape changes, and if so, what has been their experience?
Submit comments to the e-Network Forum at enetworkforum@cbbsweb.org
Ira A. Shulman, MD
CBBS e-Network Forum Senior Editor & Moderator
W. Tait Stevens, MD
CBBS e-Network Forum Editor & Moderator
Elizabeth M. St. Lezin, MD
CBBS e-Network Forum Associate Editor & Moderator
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.
